Overview

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether multiple doses of ZGN-433 are safe and effective.
Phase:
Phase 1
Details
Lead Sponsor:
Zafgen, Inc.
Treatments:
CKD732